AMDL
AMDL reports loss of $0.02 per share
Published in Health Business Week, September 15th, 2006
AMDL's total product revenues including from its DR-70 test kit for the quarter ended June 30, 2006 totaled $17,725 and for the first 6 months of 2006 totaled $33,100. This compared to revenues of $16,550 for the second quarter ended June 30, 2005 and $39,425 for the first 6 months of 2005. Gross profit totaled $11,008 for the second quarter of 2006 and $20,611 for the first 6 months of the current year, compared to $13,961 for the second quarter of 2005 and $32,008 for the first 6 months of 2005.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
Source: Health Business Week (2006-09-15)
More Articles from Health Business Week
- AMS Health Sciences
AMS Health Sciences posts profit of $0.01 per share - Aeterna Zentaris
Aeterna Zentaris reports loss of $0.03 per share - Applied Imaging
Applied Imaging incurs loss of $0.06 per share - Applied NeuroSolutions
Dutton Associates maintains Speculative Buy Rating for Applied NeuroSolutions - Aspyra
Aspyra reports loss of $0.11 per share - Australian Pharmaceutical
Australian Pharmaceutical releases results for year ended 30 April 2006 - More from this issue of Health Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
